CRISPR Industry | Sensory Seeking

The CRISPR industry has exploded since the discovery of the CRISPR-Cas9 gene editing tool in 2012 by Jennifer Doudna and Emmanuelle Charpentier, with a projected market size of $13.6 billion by 2028. Companies like CRISPR Therapeutics, Editas Medicine, and Intellia Therapeutics are leading the charge in developing CRISPR-based treatments for genetic diseases. However, the industry is not without controversy, with concerns over patent disputes, ethics, and unintended consequences. As the technology advances, we can expect to see new applications in fields like agriculture and synthetic biology. With a vibe score of 8, the CRISPR industry is poised to continue its rapid growth and transformation of the biotech landscape. Key players like Doudna and Charpentier have influenced the development of the industry, with their work building on that of earlier scientists like Francis Crick and James Watson.